Recombinant CD83 proteins and anti-CD83 antibodies that exploit the function of CD83 were demonstrated to be effective in the treatment of various mouse models of autoimmune and inflammatory diseases (such as graft rejection, RA, and inflammatory bowel disease) [48,49,50,51,52]. This evidence concerns the gene CD83 and rheumatoid arthritis.